Substance P-immunoreactive astrocytes in gracile sensory nervous tract of spinal cord in gracile axonal dystrophy mutant mouse
Tóm tắt
In the gracile axonal dystrophy (GAD) mutant mouse, the dyingback type axonal dystrophy of the primary afferent neurons in the gracile tract of the spinal cord was marked by severe gliosis characterized by the hypertrophy and proliferation of the fibrous astrocytes. Immunocytochemical observation for substance P (SP) revealed that SP-positive cells increased in the lesioned sites, primarily in the gracile nucleus of the medulla and subsequently in the gracile fasciculus of the spinal cord. The combined immunostaining of both SP and glial fibrillary acidic protein (GFAP) indicated that a strong correspondence exists between GFAP-positive networks and SP-positive grains, suggesting that SP was accumulated in the cytoplasm of astrocytes. The networks of SP-positive astrocytes spread all over the gracile tract and were densest at the subpial membrane. Similar lesions and SP activity were detected along the marginal zone of the lateral and ventral funiculi. Using an electron microscope, in addition to SP-positive axonal terminals in the gracile nucleus, most SP-positive cells in the gracile tract were identified as reactive astrocytes whose processes surrounded myelinated and nonmyelinated axons, and extended their foot processes to the blood vessels. Byin situ hybridization histochemistry of SP mRNA, we confirmed the synthesis of SP in the astrocytes. Although the functional significance of SP within astrocytes is not established here, these results imply that the astrocytes may play a role as a gliotransmitter through which the progress of axonal degeneration in the spinal cord was modified.
Tài liệu tham khảo
Arai H., Moroji T., Kosaka K., and Iizuka R. (1986) Extrahypophyseal distribution of α-melanocyte stimulating hormone (α-MSH)-like immunoreactivity in postmortem brains from normal subjects and Alzheimer-type dementia patients.Brain Res. 377, 305–310.
Bannon M. J., Poosch M. S., Haverstick D. M., Mandal A., Xue I. C. H., Shibata K., and Dragovic L. J. (1992) Preprotachykinin gene expression in the human basal ganglia: characterization of mRNAs and pre-mRNAs produced by alternate RNA splicing.Mol. Brain Res. 12, 225–231.
Erspamer V. (1981) The tachykinin peptide family.Trends Neurosci. 4, 267–269.
Fujisawa K. and Shiraki H. (1978) Study of axonal dystrophy. I. Pathology of the neurophil of the gracile and the cuneate nuclei in aging and old rats: A stereological study.Neuropathol. Appl. Neurobiol. 4, 1–20.
Helme R. D., Eglezos A., Dandie G. W., Andrews P. V., and Boyd R. L. (1987) The effect of substance P on the regional lymph node antibody response to antigenic stimulation in capsaicin-pretreated rats.J. Immunol. 139, 3470–3473.
Kage P., McGregor G. P., Thim L., and Conlon J. M. (1988). Neuropeptide γ: a peptide isolated from rabbit intestine that is derived from γ-preprotachykinin.J. Neurochem. 50, 1412–1417.
Kikuchi T., Mukoyama M., Yamazaki K., and Moriya H. (1990). Axonal degeneration of ascending sensory neurons in gracile axonal dystrophy mutant mouse.Acta Neuropathol. (Berlin) 80, 141–151.
Kostyk S. K., Kowall N. W., and Hauser S. L. (1989) Substance P immunoreactive astrocytes are present in multiple sclerosis plaques.Brain Res. 504, 284–288.
Laage S., Zobel G., and Jockush H. (1988) Astrocyte overgrowth in the brain stem and spinal cord of mice affected by spinal atrophy, wobbler.Dev. Neurosci. 10, 190–198.
Leander S., Brodin E., Hakanson R., Sundler F., and Uddman R. (1982) Neuronal substance P in the esophagus. Distribution and effects on motor activity.Acta Physiol. Scand. 115, 427–435.
Liungdahl A., Hokfelt T., and Nilsson G. (1978) Distribution of substance P-like immunoreactivity in the central nervous system of the rat. I. Cell bodies and nerve terminals.Neuroscience 3, 861–943.
Louis S. M., Jamitson A., Russell N. J. W., and Dockroy G. J. (1989) The role of substance P and calcitonin gene-related peptide in neurogenic plasma extravasation and vasodilatation in the rat.Neuroscience 32, 581–586.
Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol regent.J. Biol. Chem. 193, 265–275.
Martin D. (1992) Synthesis and release of neuroactive substances by glial cells.Glia 5, 81–94.
Matsuda T., Maeda M., Morishima Y., Hashimoto S., Tateishi K., Hamaoka T., Mizuta H., and Takagi H. (1985) Dystrophic axons in the nucleus gracilis of the normal rat containing cholecytokinin-like immunoreactivity. Light- and electron-microscopic observations.Acta Neuropathol. (Berlin) 65, 224–234.
McKeon R. J., Schreiber R. C., Rudge J. S., and Silver J. (1991) Reduction of neurite outgrowth in a model of glial scarring following CNS injury correlated with the expression of inhibitory molecules on reactive astrocytes.J. Neurosci. 11, 3398–3411.
Michel J.-P., Sakamoto N., Bouvier R., Tomasi M., and Rearson J. (1986) Substance P-immunoreactive astrocytes related to deep white matter and striatal blood vessels in human brain.Brain Res. 377, 383–387.
Mitsushio H., Takashima M., Mataga N., and Toru M. (1988) Effects of chronic treatment with trihexyphenidyl and carbamazepine alone or in combination with haloperidol on substance P content in rat brain: A possible implication of substance P in affective disordersJ. Pharmacol. Exp. Ther. 245, 982–989.
Mukoyama M., Yamazaki K., Kikuchi T., and Tomita T. (1989) Neuropathology of gracile axonal dystrophy (GAD) mouse.Acta Neuropathol. (Berlin) 79, 294–299.
Nawa H., Hirose T., Takashima H., Inayama S., and Nakanishi S. (1983) Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor.Nature 306, 32–36.
Nawa H., Kotani H., and Nakanishi S. (1984) Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing.Nature 312, 729–734.
Oda K., Yamazaki K., Miura H., Shibasaki H., and Kikuchi T. (1992) Dying back type axonal degeneration of sensory nerve terminals in muscle spindles of the gracile axonal dystrophy (GAD) mutant mouse.Neuropathol. Appl. Neurobiol. 18, 265–281.
Pernow B. and Rosell S. (1975) Effect of substance P on blood flow in canine adipose tissue and skeletal muscle.Acta Physiol. Scand. 93, 139–141.
Pernow B. (1983) Substance P.Pharmacol. Rev. 35, 86–128.
Pickel V. M., Reis D. J., and Leeman S. E. (1977) Ultrastructural localization of substance P in neurons of rat spinal cord.Brain Res. 122, 534–539.
Sidman R. L., Angevine J. B., and Pierce E. T. (1971)Atlas of the Mouse Brain and Spinal Cord. Harvard University Press, Cambridge, MA.
Smith G. M., Miller R. H., and Silver J. (1986) Changing role of forebrain astrocytes during development, regenerative failure, and induced regeneration upon transplantation.J. Comp. Neurol. 251, 23–43.
tanisz A. M., Befus D., and Bienenstock J. (1986) Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer’s patches, mesenteric lymph nodes and spleen.J. Immunol. 136, 152–156.
Sternberger L. A., Hardy P. H. Jr., Cuculis J. J., and Meyer H. G. (1970) The unlabelled antibody-enzyme method of immunohistochemistry. Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in the identification of spirochetes.J. Histochem. Cytochem. 18, 315–333.
Tang F., Cheung A., and Vacca-Galloway L. L. (1990) Measurement of neuropeptides in the brain and spinal cord of Wobbler mouse: a model for motoneuron disease.Brain Res. 518, 329–333.
Tatemoto K., Lundberg J. M., Jonvall H., Mutt V. (1985) Neuropeptide K: isolation, structure and biological activities of a novel brain tachykinin.Biochem. Biophys. Res. Commun. 128, 947–953.
Tracey D. J. (1985) Somatosensory system, inThe Rat Nervous System, vol. 2 (Paxinos G., ed.), pp. 129–152, Academic, Kensington, Australia.
Traugott U. and Raine C. S. (1985) Evidence for antigen presentation in situ by endothelial cells and astrocytes.J. Neurol. Sci. 69, 365–370.
Vacca-Galloway L. L. and Steinberger C. C. (1986) Substance P neurons sprout in the cervical spinal cord of the wobbler mouse: a model for motoneuron disease.J. Neurosci. Res. 16, 657–670.
Vogler K., Haefely W., Hurlimann A., Studer R. O., Lergier W., Strasser R., and Berneis K. H. (1963) A new purification procedure and biological properties of substance P.Ann. NY Acad. Sci. 104, 378–389.
Yamazaki K., Wakasugi N., Tomita T., Kikuchi T., Mukoyama M., and Ando K. (1988a) Gracile axonal dystrophy (GAD), a neurological mutant in the mouse.Proc. Soc. Exp. Biol. Med. 187, 209–215.
Yamazaki K., Wakasugi N., Sakakibara A., and Tomita T. (1988b) Reduced fertility in gracile axonal dystrophy (gad) mice.Exp. Anim. 37, 195–199.
Yamazaki K., Moriya H., Wakabayashi T., and Kikuchi T. (1989) Substance P-like immunoreactivity in the gracile nucleus and fasciculus in old mice.Neurosci. Lett. 106, 258–260.
Yamazaki K., Moriya H., Wakabayashi T., and Kikuchi T. (1990) Glial fibrillary acidic protein-like immunoreactivity in the central nervous system of GAD (gracile axonal dystrophy) mice.Biomed. Res. 11, 145–149.
Yamazaki K., Kobayashi A., Kumazawa A., Wakabayashi T., and Kikuchi T. (1991) Axonal degeneration in the central nervous system of gracile axonal dystrophy (GAD) mice progresses like in human spinocerebellar ataxias.Biomed. Res. 12, 143–148.
Yamazaki K., Wakabayashi T., and Kikuchi T. (1992) Occurence of axonal dystrophy in the dorsal nucleus of Clarke of BALB/c mice with aging.Biomed. Res. 13, 163–166.
Yanker B. A., Duffy L. K., and Kirschner D. A. (1990) Neurotrophic and neurotoxic effects of amyloid β protein. Reversal by tachykinin neuropeptides.Science 250, 279–282.